1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. HARMONY BIOSCIENCES HOLDINGS INC
Harmony Biosciences Holdings Inc
XNAS: HRMY
33.30 0.91 (2.81%)
36,334.6
XNAS Volume

XNAS 09 Jun, 2026 10:27 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Harmony Biosciences Holdings Inc is on 10 Jun 2026 for the purpose of Oppenheimer CNS & Neuro-Muscular Summit See details

Harmony Biosciences Holdings Inc - HRMY - stock price prediction, stock price target, analyst ratings from 11 analysts

Harmony Biosciences Holdings Inc has a share price target of US$ 44, revenue growth forecast of 16.4%, and profit growth estimate of 33.3% for FY26, based on top 11 analyst calls.